A Randomized Trial Comparing Quality of Life After Low-Dose Rate or High-Dose Rate Prostate Brachytherapy Boost With Pelvic External Beam Radiation Therapy-Reference-Cited by-同舟云学术

A Randomized Trial Comparing Quality of Life After Low-Dose Rate or High-Dose Rate Prostate Brachytherapy Boost With Pelvic External Beam Radiation Therapy

Published:2024-09 Issue:1 Volume:120 Page:59-68
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Crook Juanita^ORCID,Moideen Nikitha,Arbour Greg,Castro Felipe,Araujo Cynthia,Batchelar Deidre,Halperin Ross,Hilts Michelle,Kim David,Petrik David,Rose Jim,Cheng J.C.,Bachand Francois

Publisher

Elsevier BV

Reference30 articles.

1. Brachytherapy for patients with prostate cancer: American Society of Clinical Oncology/Cancer Care Ontario joint guideline update;Chin;J Clin Oncol,2017

2. Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer

3. Randomised trial of external-beam radiotherapy alone or with high-dose-rate brachytherapy for prostate cancer: Mature 12-year results;Hoskin;Radiother Oncol,2021

4. Brachytherapy boost for prostate cancer: Trends in care and survival outcomes;Glaser;Brachytherapy,2017

5. ASCENDE-RT: An analysis of health-related quality of life for a randomized trial comparing low-dose-rate brachytherapy boost with dose-escalated external beam boost for high- and intermediate-risk prostate cancer;Rodda;Int J Radiat Oncol Biol Phys,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of I-125 Low-Dose-Rate Brachytherapy in Patients with Localized Prostate Cancer: A Comprehensive Analysis from a Specialized Tertiary Referral Center;Journal of Personalized Medicine;2024-08-21